Quadrant and MicroDose form drug delivery joint venture
This article was originally published in Clinica
Executive Summary
UK company Quadrant Healthcare and privately held US company MicroDose Technologies are to form a joint venture company aimed at developing technology for the pulmonary delivery of peptides and proteins. The new company, QDose, will be owned equally by the two firms and will be based in the UK.